The groundbreaking rise of Viagra has consistently remained a example of pharmaceutical success, yet its legacy within the broader market now presents questions about future returns . Alternative versions are undercutting patent protection , prompting concerns that betting on companies closely tied to Viagra's once-dominant influence could be a dan